Pharmaceutical
Technology
Health
Cleveland BioLabs
$1.479876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-2.49%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell CBLI and other stocks, options, ETFs, and crypto commission-free!
About
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. Read More It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.
CEO
Employees
16
Headquarters
Buffalo, New York
Founded
2003
Market Cap
16.61M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
14.81K
High Today
$1.49
Low Today
$1.47
Open Price
$1.49
Volume
760.00
52 Week High
$3.16
52 Week Low
$1.00
Collections
Pharmaceutical
Technology
Health
Biotechnology
Biopharmaceutical
Research And Development
US
North America
Price Paid on Robinhood
43% Lower
Right Now
52 Week Low
$1.00
Average Price Paid
$2.58
52 Week High
$3.16
Earnings
-$0.11
-$0.07
-$0.04
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
-$0.08 per share